Skip to main content
SpringerLink
Log in
Book cover

Cancer Associated Viruses pp 571–583Cite as

Hepatitis C Virus and Hepatocellular Carcinoma

  • Chapter
  • First Online:

Part of the book series: Current Cancer Research ((CUCR))

Abstract

Hepatitis C virus (HCV) is strongly linked with the development of hepatocellular carcinoma. However, cancer arises in only a subset of patients, and takes several years to develop. Thus, the role of HCV in the etiology of cancer has remained elusive. I summarize here the clinical and molecular virological connections between HCV and liver cancer.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  • Abid K, Pazienza V, de Gottardi A et al (2005) An in vitro model of hepatitis C virus genotype 3a-associated triglycerides accumulation. J Hepatol 42(5):744–751

    Article  PubMed  CAS  Google Scholar 

  • Ariumi Y, Kuroki M, Dansako H et al (2008) The DNA damage sensors ataxia-telangiectasia mutated kinase and checkpoint kinase 2 are required for hepatitis C virus RNA replication. J Virol 82(19):9639–9646

    Article  PubMed  CAS  Google Scholar 

  • Battaglia S, Benzoubir N, Nobilet S et al (2009) Liver cancer-derived hepatitis C virus core proteins shift TGF-beta responses from tumor suppression to epithelial-mesenchymal transition. PLoS One 4(2):e4355

    Article  PubMed  CAS  Google Scholar 

  • Bhatia SN, Balis UJ, Yarmush ML et al (1999) Effect of cell–cell interactions in preservation of cellular phenotype: cocultivation of hepatocytes and nonparenchymal cells. FASEB J 13(14):1883–1900

    PubMed  CAS  Google Scholar 

  • Blight KJ, Kolykhalov AA, Rice CM (2000) Efficient initiation of HCV RNA replication in cell culture. Science (New York, NY) 290(5498):1972–1974

    Article  CAS  Google Scholar 

  • Blight KJ, McKeating JA, Rice CM (2002) Highly permissive cell lines for subgenomic and genomic hepatitis C virus RNA replication. J Virol 76(24):13001–13014

    Article  PubMed  CAS  Google Scholar 

  • Bruix J, Barrera JM, Calvet X et al (1989) Prevalence of antibodies to hepatitis C virus in spanish patients with hepatocellular carcinoma and hepatic cirrhosis. Lancet 2(8670):1004–1006

    Article  PubMed  CAS  Google Scholar 

  • Bruno S, Silini E, Crosignani A et al (1997) Hepatitis C virus genotypes and risk of hepatocellular carcinoma in cirrhosis: a prospective study. Hepatology (Baltimore, MD) 25(3):754–758

    Article  CAS  Google Scholar 

  • Castells L, Vargas V, Gonzalez A et al (1995) Long interval between HCV infection and development of hepatocellular carcinoma. Liver 15(3):159–163

    PubMed  CAS  Google Scholar 

  • Cheng PL, Chang MH, Chao CH et al (2004) Hepatitis C viral proteins interact with Smad3 and differentially regulate TGF-beta/Smad3-mediated transcriptional activation. Oncogene 23(47):7821–7838

    Article  PubMed  CAS  Google Scholar 

  • Chiba T, Matsuzaki Y, Abei M et al (1996) Multivariate analysis of risk factors for hepatocellular carcinoma in patients with hepatitis C virus-related liver cirrhosis. J Gastroenterol 31(4):552–558

    Article  PubMed  CAS  Google Scholar 

  • Choo Q-L, Kuo G, Weiner AJ et al (1989) Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science (New York, NY) 244:359–362

    Article  CAS  Google Scholar 

  • Chou AH, Tsai HF, Wu YY et al (2005) Hepatitis C virus core protein modulates trail-mediated apoptosis by enhancing bid cleavage and activation of mitochondria apoptosis signaling pathway. J Immunol 174(4):2160–2166

    PubMed  CAS  Google Scholar 

  • Colombo M, Kuo G, Choo QL et al (1989) Prevalence of antibodies to hepatitis C virus in italian patients with hepatocellular carcinoma. Lancet 2(8670):1006–1008

    Article  PubMed  CAS  Google Scholar 

  • De Mitri MS, Poussin K, Baccarini P et al (1995) HCV-associated liver cancer without cirrhosis. Lancet 345(8947):413–415

    Article  PubMed  Google Scholar 

  • Degos F, Christidis C, Ganne-Carrie N et al (2000) Hepatitis C virus related cirrhosis: time to occurrence of hepatocellular carcinoma and death. Gut 47(1):131–136

    Article  PubMed  CAS  Google Scholar 

  • Deng L, Nagano-Fujii M, Tanaka M et al (2006) NS3 protein of hepatitis C virus associates with the tumour suppressor p53 and inhibits its function in an NS3 sequence-dependent manner. J Gen Virol 87(Pt 6):1703–1713

    Article  PubMed  CAS  Google Scholar 

  • Deuffic S, Poynard T, Valleron AJ (1999) Correlation between hepatitis C virus prevalence and hepatocellular carcinoma mortality in Europe. J Viral Hepat 6(5):411–413

    Article  PubMed  CAS  Google Scholar 

  • Di Bisceglie AM, Shiffman ML, Everson GT et al (2008) Prolonged therapy of advanced chronic hepatitis C with low-dose peginterferon. N Engl J Med 359(23):2429–2441

    Article  PubMed  Google Scholar 

  • Donato F, Tagger A, Chiesa R et al (1997) Hepatitis B and C virus infection, alcohol drinking, and hepatocellular carcinoma: a case-control study in Italy. Brescia HCC study. Hepatology (Baltimore, MD) 26(3):579–584

    Article  CAS  Google Scholar 

  • Donato F, Boffetta P, Puoti M (1998) A meta-analysis of epidemiological studies on the combined effect of hepatitis B and C virus infections in causing hepatocellular carcinoma. Int J Cancer 75(3):347–354

    Article  PubMed  CAS  Google Scholar 

  • Donato F, Tagger A, Gelatti U et al (2002) Alcohol and hepatocellular carcinoma: the effect of lifetime intake and hepatitis virus infections in men and women. Am J Epidemiol 155(4):323–331

    Article  PubMed  CAS  Google Scholar 

  • Dustin LB, Rice CM (2007) Flying under the radar: the immunobiology of hepatitis C. Annu Rev Immunol 25:71–99

    Article  PubMed  CAS  Google Scholar 

  • El-Serag HB (2002) Hepatocellular carcinoma and hepatitis C in the United States. Hepatology (Baltimore, MD) 36(5 Suppl 1):S74–S83

    Article  Google Scholar 

  • Freeman AJ, Dore GJ, Law MG et al (2001) Estimating progression to cirrhosis in chronic hepatitis C virus infection. Hepatology (Baltimore, MD) 34(4 Pt 1):809–816

    Article  CAS  Google Scholar 

  • Gale M Jr, Kwieciszewski B, Dossett M et al (1999) Antiapoptotic and oncogenic potentials of hepatitis C virus are linked to interferon resistance by viral repression of the PKR protein kinase. J Virol 73(8):6506–6516

    PubMed  CAS  Google Scholar 

  • Ghosh AK, Steele R, Meyer K et al (1999) Hepatitis C virus NS5A protein modulates cell cycle regulatory genes and promotes cell growth. J Gen Virol 80(Pt 5):1179–1183

    PubMed  CAS  Google Scholar 

  • Gong G, Waris G, Tanveer R et al (2001) Human hepatitis C virus NS5A protein alters intracellular calcium levels, induces oxidative stress, and activates STAT-3 and NF-kappa B. Proc Natl Acad Sci USA 98(17):9599–9604

    Article  PubMed  CAS  Google Scholar 

  • Gordon SC, Bayati N, Silverman AL (1998) Clinical outcome of hepatitis C as a function of mode of transmission. Hepatology (Baltimore, MD) 28(2):562–567

    Article  CAS  Google Scholar 

  • Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144(5):646–674

    Article  PubMed  CAS  Google Scholar 

  • Honda A, Hatano M, Kohara M et al (2000a) HCV-core protein accelerates recovery from the insensitivity of liver cells to Fas-mediated apoptosis induced by an injection of anti-Fas antibody in mice. J Hepatol 33(3):440–447

    Article  PubMed  CAS  Google Scholar 

  • Honda M, Kaneko S, Shimazaki T et al (2000b) Hepatitis C virus core protein induces apoptosis and impairs cell-cycle regulation in stably transformed Chinese hamster ovary cells. Hepatology (Baltimore, MD) 31(6):1351–1359

    Article  CAS  Google Scholar 

  • Hoofnagle JH, di Bisceglie AM (1997) The treatment of chronic viral hepatitis. N Engl J Med 336(5):347–356

    Article  PubMed  CAS  Google Scholar 

  • Ishido S, Fujita T, Hotta H (1998) Complex formation of NS5b with NS3 and NS4a proteins of hepatitis C virus. Biochem Biophys Res Commun 244(1):35–40

    Article  PubMed  CAS  Google Scholar 

  • Jhaveri R, McHutchison J, Patel K et al (2008) Specific polymorphisms in hepatitis C virus genotype 3 core protein associated with intracellular lipid accumulation. J Infect Dis 197(2):283–291

    Article  PubMed  CAS  Google Scholar 

  • Kamegaya Y, Hiasa Y, Zukerberg L et al (2005) Hepatitis C virus acts as a tumor accelerator by blocking apoptosis in a mouse model of hepatocarcinogenesis. Hepatology (Baltimore, MD) 41(3):660–667

    Article  Google Scholar 

  • Kao CF, Chen SY, Chen JY et al (2004) Modulation of p53 transcription regulatory activity and post-translational modification by hepatitis C virus core protein. Oncogene 23(14):2472–2483

    Article  PubMed  CAS  Google Scholar 

  • Kawamura T, Furusaka A, Koziel MJ et al (1997) Transgenic expression of hepatitis C virus structural proteins in the mouse. Hepatology (Baltimore, MD) 25(4):1014–10121

    Article  CAS  Google Scholar 

  • Khetani SR, Bhatia SN (2008) Microscale culture of human liver cells for drug development. Nat Biotechnol 26(1):120–126

    Article  PubMed  CAS  Google Scholar 

  • Kolykhalov AA, Agapov EV, Blight KJ et al (1997) Transmission of hepatitis C by intrahepatic inoculation with transcribed RNA. Science (New York, NY) 277(5325):570–574

    Article  CAS  Google Scholar 

  • Korenaga M, Wang T, Li Y et al (2005) Hepatitis C virus core protein inhibits mitochondrial electron transport and increases reactive oxygen species (ROS) production. J Biol Chem 280(45):37481–37488

    Article  PubMed  CAS  Google Scholar 

  • Kwun HJ, Jung EY, Ahn JY et al (2001) p53-dependent transcriptional repression of p21(waf1) by hepatitis C virus NS3. J Gen Virol 82(Pt 9):2235–2241

    PubMed  CAS  Google Scholar 

  • Lai CK, Jeng KS, Machida K et al (2008) Hepatitis C virus NS3/4A protein interacts with ATM, impairs DNA repair and enhances sensitivity to ionizing radiation. Virology 370(2):295–309

    Article  PubMed  CAS  Google Scholar 

  • Lan KH, Sheu ML, Hwang SJ et al (2002) HCV NS5a interacts with p53 and inhibits p53-mediated apoptosis. Oncogene 21(31):4801–4811

    Article  PubMed  CAS  Google Scholar 

  • Lanford RE, Chavez D, Chisari FV et al (1995) Lack of detection of negative-strand hepatitis C virus RNA in peripheral blood mononuclear cells and other extrahepatic tissues by the highly strand-specific rTth reverse transcriptase PCR. J Virol 69(12):8079–8083

    PubMed  CAS  Google Scholar 

  • Lavanchy D (2009) The global burden of hepatitis C. Liver Int 29(Suppl 1):74–81

    Article  PubMed  Google Scholar 

  • Lerat H, Honda M, Beard MR et al (2002) Steatosis and liver cancer in transgenic mice expressing the structural and nonstructural proteins of hepatitis C virus. Gastroenterology 122(2):352–365

    Article  PubMed  CAS  Google Scholar 

  • Li K, Prow T, Lemon SM et al (2002) Cellular response to conditional expression of hepatitis C virus core protein in Huh7 cultured human hepatoma cells. Hepatology (Baltimore, MD) 35(5):1237–1246

    Article  CAS  Google Scholar 

  • Li K, Foy E, Ferreon JC et al (2005a) Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the toll-like receptor 3 adaptor protein TRIF. Proc Natl Acad Sci USA 102(8):2992–2997

    Article  PubMed  CAS  Google Scholar 

  • Li XD, Sun L, Seth RB et al (2005b) Hepatitis C virus protease NS3/4A cleaves mitochondrial antiviral signaling protein off the mitochondria to evade innate immunity. Proc Natl Acad Sci USA 102(49):17717–17722

    Article  PubMed  CAS  Google Scholar 

  • Liang TJ, Heller T (2004) Pathogenesis of hepatitis C-associated hepatocellular carcinoma. Gastroenterology 127(5 Suppl 1):S62–S71

    Article  PubMed  CAS  Google Scholar 

  • Liang TJ, Jeffers LJ, Reddy KR et al (1993) Viral pathogenesis of hepatocellular carcinoma in the united states. Hepatology (Baltimore, MD) 18(6):1326–1333

    CAS  Google Scholar 

  • Liang Y, Shilagard T, Xiao SY et al (2009) Visualizing hepatitis C virus infections in human liver by two-photon microscopy. Gastroenterology 137(4):1448–1458

    Article  PubMed  CAS  Google Scholar 

  • Lindenbach BD, Evans MJ, Syder AJ et al (2005) Complete replication of hepatitis C virus in cell culture. Science (New York, NY) 309(5734):623–626

    Article  CAS  Google Scholar 

  • Lindenbach BD, Thiel HJ, Rice CM (2007) Flaviviridae: the viruses and their replication. In: Knipe DM, Howley PM (eds) Fields virology, 1st edn. Lippincott-Raven Publishers, Philadelphia, pp 1101–1152

    Google Scholar 

  • Lohmann V, Korner F, Koch JO et al (1999) Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line. Science (New York, NY) 285:110–113

    Article  CAS  Google Scholar 

  • Lok AS, Seeff LB, Morgan TR et al (2009) Incidence of hepatocellular carcinoma and associated risk factors in hepatitis C-related advanced liver disease. Gastroenterology 136(1):138–148

    Article  PubMed  CAS  Google Scholar 

  • Lu W, Lo SY, Chen M et al (1999) Activation of p53 tumor suppressor by hepatitis C virus core protein. Virology 264(1):134–141

    Article  PubMed  CAS  Google Scholar 

  • Machida K, Cheng KT, Sung VM et al (2004) Hepatitis C virus induces a mutator phenotype: enhanced mutations of immunoglobulin and protooncogenes. Proc Natl Acad Sci USA 101(12):4262–4267

    Article  PubMed  CAS  Google Scholar 

  • Machida K, Liu JC, McNamara G et al (2009) Hepatitis C virus causes uncoupling of mitotic checkpoint and chromosomal polyploidy through the Rb pathway. J Virol 83(23):12590–12600

    Article  PubMed  CAS  Google Scholar 

  • Majumder M, Ghosh AK, Steele R et al (2001) Hepatitis C virus NS5A physically associates with p53 and regulates p21/waf1 gene expression in a p53-dependent manner. J Virol 75(3):1401–1407

    Article  PubMed  CAS  Google Scholar 

  • Majumder M, Steele R, Ghosh AK et al (2003) Expression of hepatitis C virus non-structural 5A protein in the liver of transgenic mice. FEBS Lett 555(3):528–532

    Article  PubMed  CAS  Google Scholar 

  • Manns MP, McHutchison JG, Gordon SC et al (2001) Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial. Lancet 358(9286):958–965

    Article  PubMed  CAS  Google Scholar 

  • Marukian S, Jones CT, Andrus L et al (2008) Cell culture-produced hepatitis C virus does not infect peripheral blood mononuclear cells. Hepatology (Baltimore, MD) 48(6):1843–1850

    Article  Google Scholar 

  • Mazzella G, Accogli E, Sottili S et al (1996) Alpha interferon treatment may prevent hepatocellular carcinoma in HCV-related liver cirrhosis. J Hepatol 24(2):141–147

    Article  PubMed  CAS  Google Scholar 

  • McGivern DR, Lemon SM (2011) Virus-specific mechanisms of carcinogenesis in hepatitis C virus associated liver cancer. Oncogene 30(17):1969–1983

    Google Scholar 

  • McGivern DR, Villanueva RA, Chinnaswamy S et al (2009) Impaired replication of hepatitis C virus containing mutations in a conserved NS5B retinoblastoma protein-binding motif. J Virol 83(15):7422–7433

    Article  PubMed  CAS  Google Scholar 

  • Meylan E, Curran J, Hofmann K et al (2005) Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature 437(7062):1167–1172

    Article  PubMed  CAS  Google Scholar 

  • Milward A, Mankouri J, Harris M (2010) Hepatitis C virus NS5A protein interacts with beta-catenin and stimulates its transcriptional activity in a phosphoinositide-3 kinase-dependent fashion. J Gen Virol 91(Pt 2):373–381

    Article  PubMed  CAS  Google Scholar 

  • Miyanari Y, Atsuzawa K, Usuda N et al (2007) The lipid droplet is an important organelle for hepatitis C virus production. Nat Cell Biol 9(9):1089–1097

    Article  PubMed  CAS  Google Scholar 

  • Moradpour D, Englert C, Wakita T et al (1996) Characterization of cell lines allowing tightly regulated expression of hepatitis C virus core protein. Virology 222(1):51–63

    Article  PubMed  CAS  Google Scholar 

  • Moriya K, Yotsuyanagi H, Shintani Y et al (1997) Hepatitis C virus core protein induces hepatic steatosis in transgenic mice. J Gen Virol 78(Pt 7):1527–1531

    PubMed  CAS  Google Scholar 

  • Moriya K, Fujie H, Shintani Y et al (1998) The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice. Nat Med 4:1065–1067

    Article  PubMed  CAS  Google Scholar 

  • Munakata T, Nakamura M, Liang Y et al (2005) Down-regulation of the retinoblastoma tumor suppressor by the hepatitis C virus NS5B RNA-dependent RNA polymerase. Proc Natl Acad Sci USA 102(50):18159–18164

    Article  PubMed  CAS  Google Scholar 

  • Munakata T, Liang Y, Kim S et al (2007) Hepatitis C virus induces E6AP-dependent degradation of the retinoblastoma protein. PLoS Pathog 3(9):1335–1347

    Article  PubMed  CAS  Google Scholar 

  • Naas T, Ghorbani M, Alvarez-Maya I et al (2005) Characterization of liver histopathology in a transgenic mouse model expressing genotype 1a hepatitis C virus core and envelope proteins 1 and 2. J Gen Virol 86(Pt 8):2185–2196

    Article  PubMed  CAS  Google Scholar 

  • Nagao Y, Tanaka K, Kobayashi K et al (2004) A cohort study of chronic liver disease in an HCV hyperendemic area of Japan: a prospective analysis for 12 years. Int J Mol Med 13(2):257–265

    PubMed  CAS  Google Scholar 

  • Nishiguchi S, Kuroki T, Nakatani S et al (1995) Randomised trial of effects of interferon-alpha on incidence of hepatocellular carcinoma in chronic active hepatitis C with cirrhosis. Lancet 346(8982):1051–1055

    Article  PubMed  CAS  Google Scholar 

  • Nomura-Takigawa Y, Nagano-Fujii M, Deng L et al (2006) Non-structural protein 4A of hepatitis C virus accumulates on mitochondria and renders the cells prone to undergoing mitochondria-mediated apoptosis. J Gen Virol 87(Pt 7):1935–1945

    Article  PubMed  CAS  Google Scholar 

  • Okuda M, Li K, Beard MR et al (2002) Mitochondrial injury, oxidative stress, and antioxidant gene expression are induced by hepatitis C virus core protein. Gastroenterology 122(2):366–375

    Article  PubMed  CAS  Google Scholar 

  • Otsuka M, Kato N, Lan K et al (2000) Hepatitis C virus core protein enhances p53 function through augmentation of DNA binding affinity and transcriptional ability. J Biol Chem 275(44):34122–34130

    Article  PubMed  CAS  Google Scholar 

  • Park CY, Choi SH, Kang SM et al (2009) Nonstructural 5a protein activates beta-catenin signaling cascades: implication of hepatitis C virus-induced liver pathogenesis. J Hepatol 51(5):853–864

    Article  PubMed  CAS  Google Scholar 

  • Parkin DM, Bray F, Ferlay J et al (2005) Global cancer statistics, 2002. CA Cancer J Clin 55(2):74–108

    Article  PubMed  Google Scholar 

  • Pasquinelli C, Shoenberger JM, Chung J et al (1997) Hepatitis C virus core and E2 protein expression in transgenic mice. Hepatology (Baltimore, MD) 25(3):719–727

    Article  CAS  Google Scholar 

  • Pavio N, Battaglia S, Boucreux D et al (2005) Hepatitis C virus core variants isolated from liver tumor but not from adjacent non-tumor tissue interact with Smad3 and inhibit the TGF-beta pathway. Oncogene 24(40):6119–6132

    Article  PubMed  CAS  Google Scholar 

  • Pereira AA, Jacobson IM (2009) New and experimental therapies for HCV. Nat Rev Gastroenterol Hepatol 6(7):403–411

    Article  PubMed  CAS  Google Scholar 

  • Pietschmann T, Lohmann V, Kaul A et al (2002) Persistent and transient replication of full-length hepatitis C virus genomes in cell culture. J Virol 76(8):4008–4021

    Article  PubMed  CAS  Google Scholar 

  • Pietschmann T, Kaul A, Koutsoudakis G et al (2006) Construction and characterization of infectious intragenotypic and intergenotypic hepatitis C virus chimeras. Proc Natl Acad Sci USA 103(19):7408–7413

    Article  PubMed  CAS  Google Scholar 

  • Pietschmann T, Zayas M, Meuleman P et al (2009) Production of infectious genotype 1b virus particles in cell culture and impairment by replication enhancing mutations. PLoS Pathog 5(6):e1000475

    Article  PubMed  CAS  Google Scholar 

  • Ploss A, Khetani SR, Jones CT et al (2010) Persistent hepatitis C virus infection in microscale primary human hepatocyte cultures. Proc Natl Acad Sci USA 107(7):3141–3145

    Article  PubMed  CAS  Google Scholar 

  • Podevin P, Carpentier A, Pene V et al (2010) Production of infectious hepatitis c virus in primary cultures of human adult hepatocytes. Gastroenterology 139(4):1355–1364

    Google Scholar 

  • Prikhod’ko EA, Prikhod’ko GG, Siegel RM et al (2004) The NS3 protein of hepatitis C virus induces caspase-8-mediated apoptosis independent of its protease or helicase activities. Virology 329(1):53–67

    Article  PubMed  CAS  Google Scholar 

  • Qadri I, Iwahashi M, Simon F (2002) Hepatitis C virus NS5A protein binds TBP and p53, inhibiting their DNA binding and p53 interactions with TBP and ERCC3. Biochim Biophys Acta 1592(2):193–204

    PubMed  CAS  Google Scholar 

  • Ray RB, Steele R, Meyer K et al (1998) Hepatitis C virus core protein represses p21WAF1/Cip1/Sid1 promoter activity. Gene 208(2):331–336

    Article  PubMed  CAS  Google Scholar 

  • Resnick RH, Koff R (1993) Hepatitis C-related hepatocellular carcinoma. Prevalence and significance. Arch Intern Med 153(14):1672–1677

    Article  PubMed  CAS  Google Scholar 

  • Sacco R, Tsutsumi T, Suzuki R et al (2003) Antiapoptotic regulation by hepatitis C virus core protein through up-regulation of inhibitor of caspase-activated DNase. Virology 317(1):24–35

    Article  PubMed  CAS  Google Scholar 

  • Serfaty L, Aumaitre H, Chazouilleres O et al (1998) Determinants of outcome of compensated hepatitis C virus-related cirrhosis. Hepatology (Baltimore, MD) 27(5):1435–1440

    Article  CAS  Google Scholar 

  • Siavoshian S, Abraham JD, Kieny MP et al (2004) HCV core, NS3, NS5A and NS5B proteins modulate cell proliferation independently from p53 expression in hepatocarcinoma cell lines. Arch Virol 149(2):323–336

    Article  PubMed  CAS  Google Scholar 

  • Steinkühler C (2004) Hepacivirin. In: Barrett AJ, Rawlings ND, Woessner JF (eds) Handbook of proteolytic enzymes, 2nd edn. Elsevier, London, pp 1773–1779

    Google Scholar 

  • Street A, Macdonald A, Crowder K et al (2004) The hepatitis C virus NS5A protein activates a phosphoinositide 3-kinase-dependent survival signaling cascade. J Biol Chem 279(13):12232–12241

    Article  PubMed  CAS  Google Scholar 

  • Street A, Macdonald A, McCormick C et al (2005) Hepatitis C virus NS5A-mediated activation of phosphoinositide 3-kinase results in stabilization of cellular beta-catenin and stimulation of beta-catenin-responsive transcription. J Virol 79(8):5006–5016

    Article  PubMed  CAS  Google Scholar 

  • Sung VM, Shimodaira S, Doughty AL et al (2003) Establishment of B-cell lymphoma cell lines persistently infected with hepatitis C virus in vivo and in vitro: the apoptotic effects of virus infection. J Virol 77(3):2134–2146

    Article  PubMed  CAS  Google Scholar 

  • Tanaka Y, Hanada K, Mizokami M et al (2002) A comparison of the molecular clock of hepatitis C virus in the United States and Japan predicts that hepatocellular carcinoma incidence in the United States will increase over the next two decades. Proc Natl Acad Sci USA 99(24):15584–15589

    Article  PubMed  CAS  Google Scholar 

  • Tanaka M, Nagano-Fujii M, Deng L et al (2006) Single-point mutations of hepatitis C virus NS3 that impair p53 interaction and anti-apoptotic activity of NS3. Biochem Biophys Res Commun 340(3):792–799

    Article  PubMed  CAS  Google Scholar 

  • Tong MJ, el-Farra NS, Reikes AR et al (1995) Clinical outcomes after transfusion-associated hepatitis C. N Engl J Med 332(22):1463–1466

    Article  PubMed  CAS  Google Scholar 

  • Umemura T, Ichijo T, Yoshizawa K et al (2009) Epidemiology of hepatocellular carcinoma in Japan. J Gastroenterol 44(Suppl 19):102–107

    Article  PubMed  Google Scholar 

  • Valla DC, Chevallier M, Marcellin P et al (1999) Treatment of hepatitis C virus-related cirrhosis: a randomized, controlled trial of interferon alfa-2b versus no treatment. Hepatology (Baltimore, MD) 29(6):1870–1875

    Article  CAS  Google Scholar 

  • Wakita T, Pietschmann T, Kato T et al (2005) Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat Med 11(7):791–796

    Article  PubMed  CAS  Google Scholar 

  • Wang AG, Lee DS, Moon HB et al (2009) Non-structural 5A protein of hepatitis C virus induces a range of liver pathology in transgenic mice. J Pathol 219(2):253–262

    Article  PubMed  CAS  Google Scholar 

  • Yanagi M, Purcell RH, Emerson SU et al (1997) Transcripts from a single full-length cDNA clone of hepatitis C virus are infectious when directly transfected into the liver of a chimpanzee. Proc Natl Acad Sci USA 94(16):8738–8743

    Article  PubMed  CAS  Google Scholar 

  • Yi M, Villanueva RA, Thomas DL et al (2006) Production of infectious genotype 1a hepatitis C virus (hutchinson strain) in cultured human hepatoma cells. Proc Natl Acad Sci USA 103(7):2310–2315

    Article  PubMed  CAS  Google Scholar 

  • Yoshizawa H (2002) Hepatocellular carcinoma associated with hepatitis C virus infection in Japan: projection to other countries in the foreseeable future. Oncology 62(Suppl 1):8–17

    Article  PubMed  Google Scholar 

  • Zhong J, Gastaminza P, Cheng G et al (2005) Robust hepatitis C virus infection in vitro. Proc Natl Acad Sci USA 102(26):9294–9299

    Article  PubMed  CAS  Google Scholar 

  • Zhu N, Khoshnan A, Schneider R et al (1998) Hepatitis C virus core protein binds to the cytoplasmic domain of tumor necrosis factor (TNF) receptor 1 and enhances TNF-induced apoptosis. J Virol 72(5):3691–3697

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Section of Microbial Pathogenesis, Yale University School of Medicine, 354C Boyer Center for Molecular Medicine, 295 Congress Avenue, New Haven, CT, 06536-0812, USA

    Brett Lindenbach

Authors
  1. Brett Lindenbach
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Brett Lindenbach .

Editor information

Editors and Affiliations

  1. Perelman School of Medicine, University of Pennsylvania, Hamilton Walk 3610, Philadelphia, 19104, Pennsylvania, USA

    Erle S. Robertson

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Lindenbach, B. (2012). Hepatitis C Virus and Hepatocellular Carcinoma. In: Robertson, E. (eds) Cancer Associated Viruses. Current Cancer Research. Springer, Boston, MA. https://doi.org/10.1007/978-1-4614-0016-5_23

Download citation

  • DOI: https://doi.org/10.1007/978-1-4614-0016-5_23

  • Published:

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4419-9999-3

  • Online ISBN: 978-1-4614-0016-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation